WELL Health Technologies Corp. Announces Management Cease Trade Order
Vancouver, BC – April 1, 2025 – WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF), a digital healthcare company dedicated to enhancing health outcomes through technology, has received a Management Cease Trade Order (MCTO) from the British Columbia Securities Commission (BCSC).
The order comes as a result of WELL’s delay in submitting its annual information form, audited financial statements, and management’s discussion for the year ending December 31, 2024. The MCTO restricts the company’s Chief Executive Officer and Chief Financial Officer from trading the company’s securities until the necessary filings are completed. During this time, the company has also committed to not issuing or acquiring securities from its insiders or employees.
Importantly, this order does not limit the ability of shareholders who are not insiders to trade their shares in the company. Once the annual filings are ready, the company will release a statement to announce their completion.
In the meantime, WELL Health is adhering to alternative information guidelines under National Policy 12-203 regarding Management Cease Trade Orders. This includes publishing bi-weekly updates on their situation through news releases that will also be filed on SEDAR+.
The delay in filing was previously mentioned in WELL’s news release dated March 28, 2025. The company is actively working to complete its filings as soon as possible.
About WELL Health Technologies Corp.
WELL Health Technologies is on a mission to empower healthcare providers with technology. The company develops innovative services and support to enhance patient outcomes. Its comprehensive health and digital platform offers a range of management software applications designed to help physicians effectively run their practices. WELL serves over 41,000 healthcare providers across Canada and the U.S., leading the largest healthcare ecosystem in Canada with more than 200 clinics that specialize in primary care, specialized care, and diagnostics. In the U.S., WELL focuses on markets such as gastrointestinal health, women’s health, primary care, and mental health. For more information, visit WELL’s website.
Source: WELL Health Technologies Corp.
